Boryung, Sky Labs to validate wearable astronaut blood-pressure monitoring for space healthcare data platform
The companies will test Sky Labs' cuffless ring-type blood pressure monitor in Boryung's space-simulation laboratory and space infrastructure to verify performance under microgravity.

Boryung announced on Nov. 3 that it signed a memorandum of understanding with medical device company Sky Labs to develop biosignal monitoring solutions for astronauts and build a space healthcare data platform, Humans In Space reported.
Under the MOU, the companies will test Sky Labs' wearable products, including a cuffless ring-type blood pressure monitor, in Boryung's space-simulation laboratory and space infrastructure to verify performance under microgravity, according to Humans In Space.
Boryung said the partnership follows its agreement with the German Aerospace Center, or DLR, and secures a potential domestic customer for its space life science research infrastructure, Humans In Space reported.
Boryung will provide testing environments tailored to each research project and pursue follow-up joint research through its Humans In Space program, according to Humans In Space.
The companies will explore integrating space healthcare research data generated through Humans In Space with Sky Labs' AI-driven medical data platform, Humans In Space reported.
Sky Labs previously completed blood-pressure measurement tests of its cuffless ring-type monitor in near-weightless conditions of 0–0.1g created through parabolic flight with the University of Cambridge and the International Institute for Astronautical Sciences, according to Humans In Space.
Korea Biomedical Review reported that the agreement covers development and testing of astronaut vital-sign monitoring solutions and cooperation on a space medicine data platform.
Boryung said it has invested in Axiom Space and Intuitive Machines and established BRAX Space, a joint venture with Axiom Space, to secure domestic business rights for space research infrastructure, Humans In Space reported.
Korea Biomedical Review said the MOU signing photo showed Lim Dong-joo, head of Boryung's strategic business division, and Sky Labs CEO Lee Byung-hwan at Boryung's headquarters in Jongno-gu, Seoul, on Oct. 20.





